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いて，前肢にかかる垂直方向の力は約 800kg であり，最大運動時の前肢には 1
トンを超える力が加わる[27]．そのため，競走中に四肢の骨や腱・靱帯に適応
限界を超える力が加わることで，重大な損傷を起こす危険がある [33]．日本中




果であった [4, 8]． 
過去に「馬に麻酔をかけると速く走れなくなる」と全身麻酔下で手術をする
ことがタブー視されていた時代があった．社台ホースクリニックでは，これま









について調査している．その報告によると，2003 年から 2017 年の 15年間に

































































































































る．本症は，ダート 1000 レースにつき 0.94，芝 1000 レースにつき 0.58 の
割合で受傷する．浅屈腱炎の罹患率は，2歳馬の 6%，3歳馬の 20%，4歳馬









































症例馬と対照馬の比較について，continuous variables は，student-t test に
よって，有意差検定を実施した．また，categorical variables は，カイ二乗検















着順は，症例馬群が対象馬群よりも有意に悪かった（P < 0.01）．着順が 10
着以下であった場合に，浅屈腱炎のオッズ比が有意に高かった（OR = 2.50; P 
< 0.01）．また，競走距離は，1,300m未満であった場合に浅屈腱炎のオッズ
比は有意に高かった（OR = 1.45; P < 0.05）．さらに，馬券の人気が 8番よ
り悪かった場合に，浅屈腱炎のオッズ比は有意に高かった（OR = 1.49; P < 
0.05）． 
 
３）馬関連の危険因子（表 1, 4） 
出走時の馬の体重は，症例馬群が対照馬群よりも有意に重かった（P < 
0.01）.また，浅屈腱炎発症馬の体重は 470kg より重い場合に，浅屈腱炎のオ
ッズ比は有意に高かった（OR = 1.55; P < 0.01）．さらに，前回出走から体
重 5kg 以上減少していた場合に，浅屈腱炎のオッズ比は有意に高かった（OR 
= 1.59; P < 0.05）． 
雄と去勢雄は，雌よりも浅屈腱炎のオッズ比は有意に高かった（雄：OR= 




< 0.01）．直近 3レースの競走距離が 4,000 メートル未満であった場合に，浅
屈腱炎のオッズ比は有意に高かった（OR = 1.40; P < 0.05）．また，直近 6
レースの競走距離は，症例馬群が対照馬群よりも有意に短かった（P < 
0.05）．直近 6レースの競走距離が 8,000 メートル未満であった場合に，浅屈
腱炎のオッズ比は有意に高かった（OR = 1.47; P < 0.05）． 
前回出走からの出走間隔は，症例馬群が対照馬群よりも有意に長かった（P 
< 0.05）．出走間隔が 90日以上であった場合に，浅屈腱炎のオッズ比は有意


















































































































から 2015 年までの 5年間の大井競馬場の医療記録から，浅屈腱炎と診断され
た馬 292 頭を症例馬群として選出した．対照馬は，浅屈腱炎を発症した症例馬
と同じ調教師，同時期に出走，同じ年齢であることを選出の条件とし，浅屈腱












有意に高かった（OR= 1.69; P <0.01）．出走時の天候は，症例馬群と対照馬
群との間に差を認めなかった．レース関連の危険因子では，着順は，症例馬群
が対象馬群よりも有意に悪かった（P < 0.01）．着順が 10着以下であった場
合に，浅屈腱炎のオッズ比が有意に高かった（OR = 2.50; P < 0.01）．ま
た，競走距離は，1,300m未満であった場合に浅屈腱炎のオッズ比は有意に高
かった（OR = 1.45; P < 0.05）．さらに，馬券の人気が 8番より悪かった場
合に，浅屈腱炎のオッズ比は有意に高かった（OR = 1.49; P < 0.05）．馬関
連の危険因子では，出走時の馬の体重は，症例馬群が対照馬群よりも有意に重
かった（P < 0.01）.また，浅屈腱炎発症馬の体重は 470kg より重い場合に，
浅屈腱炎のオッズ比は有意に高かった（OR = 1.55; P < 0.01）．さらに，前
回出走から体重 5kg 以上減少していた場合に，浅屈腱炎のオッズ比は有意に高
かった（OR = 1.59; P < 0.05）．雄と去勢雄は，雌よりも浅屈腱炎のオッズ
比は有意に高かった（雄：OR= 1.35; P<0.05，去勢雄：OR=3.09; P < 
0.01）．競走歴関連の危険因子では，直近 3レースの競走距離は，症例馬群が
対照馬群よりも有意に短かった（P < 0.01）．直近 3レースの競走距離が
4,000 メートル未満であった場合に，浅屈腱炎のオッズ比は有意に高かった
（OR = 1.40; P < 0.05）．また，直近 6レースの競走距離は，症例馬群が対
照馬群よりも有意に短かった（P < 0.05）．直近 6レースの競走距離が 8,000
メートル未満であった場合に，浅屈腱炎のオッズ比は有意に高かった（OR = 
1.47; P < 0.05）．前回出走からの出走間隔は，症例馬群が対照馬群よりも有
意に長かった（P < 0.05）．出走間隔が 90日以上であった場合に，浅屈腱炎
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Analysis of the risk factors for superficial digital flexor tendinopathy in racing horses 
 
Yoko Ikeda (Graduate School of Veterinary Medicine, Azabu University) 
 
Racehorses are a specific species of athletic horses that frequently develop 
orthopedic diseases. In this study, we focused on superficial digital flexor (SDF) 
tendinopathy, which is prevalent among thoroughbred racehorses. In chapter 1, literature 
discussing the pathology, diagnosis, and treatment of SDF tendinopathy is reviewed. 
SDF tendinopathy is an orthopedic disease that causes degeneration and bleeding in the 
SDF tendon. Eventually, the damaged areas of the SDF are replaced by scar tissue, and 
recurrence becomes more frequent because of the loss of toughness associated with scar 
tissue development. In addition, the treatment for SDF tendinopathy requires a long time. 
Furthermore, diagnosing whether the injury has been completely healed can be difficult, 
and no reliable treatment method has been established so far. Therefore, preventing the 
onset of this disease is essential to avoid great economic loss. 
In chapter 2, an analysis was performed to identify risk factors associated with 
the development of SDF tendinopathy in racing horses. The authors selected racehorses 
(n = 292) diagnosed with SDF tendinopathy based on the medical records from a racetrack. 
Among the track-related variables that were identified as risk factors, a sloppy track 
surface was associated with a significantly higher risk of SDF tendinopathy than a 
standard track surface (odds ratio: OR = 1.69; P < 0.01). No significant differences in the 
weather conditions at race times were identified between racehorses with SDF 
tendinopathy and control racehorses. Among the race-related variables that were 
identified as risk factors, the OR for SDF tendinopathy was significantly increased for 
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the following variables: (i) when the horse finished in 10th place or worse (OR = 2.50; P 
< 0.01); (ii) when the racehorse ran a short race (<1,300 m) (OR = 1.45; P < 0.05); and 
(iii) when the racehorses’ favorites were worse than or equal to the 8th place (OR = 1.49; 
P < 0.05). Among the racehorse-related variables that were identified as risk factors, the 
body weights of racehorses with SDF tendinopathy, for the race during which SDF 
tendinopathy occurred, was significantly heavier than the body weights of control 
racehorses (P < 0.01). When the body weight at race time was ³ 470 kg, the SDF 
tendinopathy OR increased significantly (OR = 1.55; P < 0.01). A decrease in body 
weight ³ 5 kg compared with the body weight recorded in the previous race significantly 
increased the SDF tendinopathy OR (OR = 1.59; P < 0.05). In addition, male and gelding 
horses had higher SDF tendinopathy ORs (OR = 1.35; P < 0.05 and OR =3.09; P < 0.01, 
respectively) compared with female horses. No significant differences were identified in 
horse ages between SDF tendinopathy and control racehorses. Among the race career-
related variables that were identified as risk factors, When the total race distance for the 
last 3 races was < 4,000 m and the total race distance for the last 6 races was < 8,000 m, 
the SDF tendinopathy OR increased significantly (OR = 1.40; P < 0.05 and OR = 1.47; 
P < 0.05, respectively). When the number of days since the previous race was ³ 90-days, 
the SDF tendinopathy OR increased significantly (OR = 1.75; P < 0.05). No significant 
differences were identified with respect to a history of other diseases between SDF 
tendinopathy and control horses. A total of 0.69% of the studied horses (2/292) had a 
history of SDF tendinopathies. 
As a countermeasure for the prevention of SDF tendinopathy, sloppy track 
surfaces should be avoided, and horses should be guided toward more solid track surfaces. 
Selecting long-distance races with slower speeds, if possible, could also reduce the risks 
of horses developing SDF tendinopathy. Informing horse owners and trainers of the 
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results of this analysis will contribute to reducing the number of racehorses whose active 
lives are disrupted by the development of SDF tendinopathy. 
 
A part of this thesis was published in the Journal of Equine Science (30, 93–98, 
2019), entitled “Risk factors for superficial digital flexor tendinopathy in Thoroughbred 
racing horses in Japan.” 
 
